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day 1 discharge 3-B months
LP + (WMI-EF) 43.2±81 453 ± 78 44.1 ± 93
LP - (WMI-EF) 46.8 ± 9.9 51.3 ± 87 531 ± 8.7
p = NS p < 0.03 p < 0.01
Abnormal Signal Averaged Electrocardiogram
Predicts Mortality in Patients with Non-Ischemic
Cardiomyopathy and Severe Congestive Heart
Failure
Daniel M. Bloomfield, Kathleen Hickey, Robert R. Sciacca, Marlon S. Rosenbaum,
James Coromilas. Columbia University. New York, NY
tionaI Td (40 Hz, Butterworth filter) and STA analysis were performed using
Del Mar 183 software. Result There were significant differences in all STA
parameters (low slice correlation ratio, interslice correlation mean. interslice
correlation standard deviation and spectral entropy) between SD/PHF and
stable patients (p < 0.01). but in none of the Td parameters (tORS. LAD40.
RMS401. SD/PHF was more likely in patients with an abnormal (2::3 abnor-
mal STA parameters) compared to a normal STA result (56% vs 19%; p =
0.005). There was a significant difference in event free survival at 1 year be-
tween patients with abnormal and normal STA (61 % vs 88%; P = 0.03), but
the presence of late potentials was not discriminatory (72% vs 82%; P =
0.4). The sensitivity. specificity and total predictive accuracy for predicting
SD/PHF were 29%, 85% and 69% (p = 0.2) for Td and 53%, 83% and 74%
(p = 0.005) for STA analysis. The positive predictive characteristics curves
showed that higher positive predictive accuracies were achieved by STA
compared to those of Td analysis. The differences were significant at dif-
ferent sensitivity levels (at 50%. 60%. 70%. p = 0.05; 80%. p = 0.01). The
relative risk (95% Cl) of SD/PHF was 2.1 (0.7-6.0) for presence of late poten-
tials and 3.5 (1.4--9.2) for abnormal STA result. Conclusion STA analysis of
SAECG is a more sensitive and specific predictor of SD/PHF than Td analysis
for IDC patients and has an important role in clinical management.
Patients with severe congestive heart failure have a high mortality; many
deaths are thought to be arrhythmic. The presence of late potentials on sig-
nal averaged electrocardiograms (SAECG) identifies a substrate for reentrant
ventricular arrhythmias. We evaluated the prevalence and prognostic sig-
nificance of an abnormal SAECG in a prospectively followed population of
patients undergoing evaluation for cardiac transplantation. Ninety patients
were followed for a mean of 447 days. Twenty-six patients died and 17 pa-
tients were censored on the day of transplantation. Kaplan-Meier survival
curves were constructed and the effect of SAECG variables was tested with
a log-rank test. Fifty-four percent of the patients had a non-ischemic car-
diomyopathy and the remainder had an ischemic cardiomyopathy. Fifteen
patients had BBB and were excluded from this analysis. The average ORS
duration on 12 lead ECG was similar in ischemic cardiomyopathy and non-
ischemic cardiomyopathy groups (116 ± 23 vs 115 ± 19 ms, p = ns) and
the average toRS duration was similar in ischemic cardiomyopathy and non-
ischemic cardiomyopathy groups (131 ± 26 vs 132 ± 21 ms. p = ns). Forty-
four percent of the non-ischemic cardiomyopathy group and 50% of the is-
chemic cardiomyopathy group had an abnormal SAECG (defined as having
2 ofthe following: fORS > 114 msec. RMS < 20 fLV. LAS > 38 msec). An ab-
normal SAECG was associated with mortality in the non-ischemic cardiomy-
opathy group (p < 0.05) but not in the ischemic cardiomyopathy group (p
= ns). Twenty-eight patients had ORS duration 2:: 120 ms on 12 lead ECG.
When these patients were excluded, 20% of the non-ischemic cardiomyopa-
thy group and 41 % of the ischemic cardiomyopathy group had an abnormal
SAECG and an abnormal SAECG still predicted mortality in non-ischemic car-
diomyopathy group (p < 0.001) but not in ischemic cardiomyopathy group (p
= ns). In conclusion, an abnormal SAECG is associated with increased mor-
tality in non-ischemic cardiomyopathy but not in ischemic cardiomyopathy.
1961-821
Surface Laplacian ECG Maps Provide a Sensitive
and Localizing Measure of Cardiac Ischemia
David E. Leeman, Samuel J. Shubrooks, Kevin S. Librett, Paul E. Grimshaw,
Richard J. Cohen. Deaconess Hospital, Boston, MA; Massachusetts Ins~'tutue of
Technology, Cambridge, MA
At discharge LP was present in 12/28 pts on placebo and 2/28 pts on
enalapril (p < 0.01). At 3-6 months LP was present in 11/27 pts on placebo
and 3/28 on enalapril (p < 0.05).
Thus 1} LP predicts a lack of improvement in left ventricular function and 2)




evaluate 1) the association between LP and a change in left ventricular func-
tion and 2) the effect of acute «24 h) Lv. enaprilat followed by 3-6 months
of oral enalapril on the presence of LP.
Left ventricular function was evaluated by echocardiography day one, at
discharge and after 3-6 months using global wall motion determined ejec-
tion fraction (WMI-EF). LP was measured at discharge and after 3-6 months
using 2 out of 3 criteria (40 Hz): 1. ORS-duration > 115 ms, 2. RMS 40 < 20
microV and 3. LAS > 38 ms.
At discharge LP was present in 25% In = 14) of the pts prospectively
randomised to enalapril (n = 28)1placebo (n = 28).
WMI-EF in pts withlwithout LP at discharge:
To test the hypothesis that Laplacian surface electrocardiography provides
a sensitive and local measure of coronary ischemia, we studied six consec-
utive patients undergoing balloon angioplasty. Three self-adhesive pads of
electrodes containing 84 multipolar Laplacian electrodes were applied to
the anterior and left-lateral thorax. Laplacian electrograms and a standard
12 lead ECG were recorded prior to and during each balloon inflation. The
ratio of ST segment shift to baseline ORS amplitude (ST/O) was computed
for the Laplacian electrodes and the standard 12 leads. Defining ST/O = 0.1
to be the minimum significant ST shift, Laplacian maps in all six patients re-
vealed a significant ST shift during balloon inflation while the 12 lead ECG
revealed a significant 5T shift in only three patients. The mean peak value of
ST/O in the Laplacian maps was 0.40 versus 0.13 in the 12 lead ECG (p =
0.01). Laplacian maps of ST/O showed localized elevation over the expected
region of distribution of the occluded vessel, often surrounded by a region
of negative ST/O. The unipolar leads revealed a diffuse bipolar pattern of ST
segment shift. Conclusion: Body surface Laplacian mapping may provide a
sensitive and accurate noninvasive means of detecting and localizing cardiac
ischemia, superior to the 12 lead ECG.
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Laplacian ST/O map during distal left anterior descending coronary artery
occlusion.
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Rest TI201(TI}/stress Tc-sestamibi dual isotope SPECT (DIMPS) is an effi-
cient myocardial perfusion protocol. Patients with rest defects. however, fre-
quently require late TI redistribution imaging the next day. Thus. we recently
implemented a modified DIMPS (M-DIMPS). with 3.5 mCi TI injected at rest
the night before stress testing. On the day of stress testing, 12-18 hr redis-
tribution TI (late TI) SPECT was performed prior to stress sestamibi study.
Yi Gang, Philip J. Keeling, Jonathan H. Goldman, Katerina Hnatkova, Sonia Bent,
William J. McKenna, Marek Malik. Department of Cardiological Sciences, Sf George's
Hospital Medical School, London, UK
Identification of patients with idiopathic dilated cardiomyopathy (IDC) with
poor prognosis [sudden death (SO) or progressive heart failure (PHF)] repre-
sents a major management problem. The signal averaged electrocardiogram
(SAECG) is potentially a non-invasive marker of clinical outcome in IDe. This
study compared the ability of time domain (Td) and spectral turbulence anal-
ysis (STA) of the SAECG to predict SD/PHF in IDC patients. SAECG were
recorded in 58 consecutive patients with IDC (WHO criteria; age 41 ± 14
years) presenting to our hospital and followed over 26 ± 19 months. During
the follow up 17 patients had SD/PHF and 41 remained symptomatically and
echocardiographically stable. In this population, 27 patients with left bundle
branch block or who took anti-arrhythmic drugs had been excluded. Conven-
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